Advanced search
Publication Cover
Biomarkers Volume 22, 2017 - Issue 7
Submit an article Journal homepage
117
Views
5
CrossRef citations to date
0
Altmetric
Research Article

H19 non-coding RNA in urine cells detects urothelial carcinoma: a pilot study

Ilan GielchinskyDepartment of Urology, Hadassah – Hebrew University Medical Centre, Jerusalem, Israel; View further author information
,
Michal GilonDepartment of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, Israel; View further author information
,
Rasha Abu-lailDepartment of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, Israel; View further author information
,
Imad MatoukDepartment of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, Israel; View further author information
,
Avraham HochbergDepartment of Biological Chemistry, Institute of Life Sciences, the Hebrew University, Jerusalem, Israel; View further author information
,
Ofer N. GofritDepartment of Urology, Hadassah – Hebrew University Medical Centre, Jerusalem, Israel; View further author information
&
Iddo Z. Ben-DovNephrology and Hypertension Services, Hadassah – Hebrew University Medical Centre, Jerusalem, IsraelCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9180-3604View further author information
ORCID Icon show all
Pages 661-666 | Received 19 May 2016, Accepted 15 Dec 2016, Published online: 22 Mar 2017

References

  • Amit, D. and Hochberg, A., 2010. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. J Transl Med 8, 134.
  • Ariel, I., et al., 1997. The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol 50, 34–44.
  • Avritscher, E.B., et al., 2006. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology 68, 549–553.
  • Ayesh, S., et al., 2002. Possible physiological role of H19 RNA. Mol Carcinog 35, 63–74.
  • Babjuk, M., et al., 2013. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64, 639–653.
  • Bartolomei, M.S., Zemel, S., and Tilghman, S.M., 1991. Parental imprinting of the mouse H19 gene. Nature 351, 153–155.
  • Brannan, C.I., et al., 1990. The product of the H19 gene may function as an RNA. Mol Cell Biol 10, 28–36.
  • Breen, V., et al., 2015. A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets. BMC Med Res Methodol 15, 45.
  • Burger, M., et al., 2013. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63, 234–241.
  • Cerrato, F., et al., 2008. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Hum Mol Genet 17, 1427–1435.
  • Gromov, P., et al., 2013. Tumor interstitial fluid – a treasure trove of cancer biomarkers. Biochim Biophys Acta 1834, 2259–2270.
  • Halling, K.C., et al., 2000. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164, 1768–17775.
  • International Federation of Clinical Chemistry (IFCC). Scientific Committee, Clinical Section, 1984. Expert panel on theory of reference values (EPTRV). IFCC document (1982) stage 2, draft 2, 1983-10-07 with a proposal for an IFCC recommendation. The theory of reference values. Part 2. Selection of individuals for the production of reference values. Clin Chim Acta; Int J Clin Chem 139, 205F–213F.
  • Luo, M., et al., 2013. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 333, 213–221.
  • Matouk, I., et al., 2013. The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention. Int J Mol Sci 14, 4298–4316.
  • Matouk, I.J., et al., 2007. The H19 non-coding RNA is essential for human tumor growth. PLoS One 2, e845.
  • Matouk, I.J., et al., 2014. Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta 1843, 1414–1426.
  • Mowatt, G., et al., 2010. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 14, 1–331. iii-iv.
  • Rachmilewitz, J., et al., 1992. Parental imprinting of the human H19 gene. FEBS Lett 309, 25–28.
  • Raitanen, M.P., et al., 2002. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 41, 284–289.
  • Robin, X., et al., 2011. pROC: an open-source package for R and S + to analyze and compare ROC curves. BMC Bioinformatics 12, 77.
  • Sapre, N., et al., 2014. Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise? Urol Oncol 32, 48 e9–17.
  • Schlake, A., et al., 2012. NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study. Can J Urol 19, 6345–6350.
  • Schrag, D., et al., 2003. Adherence to surveillance among patients with superficial bladder cancer. J Natl Cancer Inst 95, 588–597.
  • Sidi, A.A., et al., 2008. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol 180, 2379–2383.
  • Toma, M.I., et al., 2004. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol 22, 145–149.
  • van Rhijn, B.W., van der Poel, H.G., and van der Kwast, T.H., 2005. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47, 736–748.
  • Webber, A.L., et al., 1998. Location of enhancers is essential for the imprinting of H19 and Igf2 genes. Nature 391, 711–715.
  • Wickham, H., 2009. ggplot2: elegant graphics for data analysis. New York: Springer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.